86
Views
2
CrossRef citations to date
0
Altmetric
Review

Defensins as anti-infective and immunomodulatory agents

Pages 1223-1234 | Published online: 31 Aug 2006

Bibliography

  • ANDREU D, RIVAS L: Animal antimicrobial peptides: an overview. Biopolymers (1998) 47:415-433.
  • ZASLOFF M: Antimicrobial peptides of multicellular organisms. Nature (2002) 415:389-395.
  • TOKE O: Antimicrobial peptides: new candidates in the fight against bacterial infections. Biolpolymers (2005) 80:717-735.
  • MYGIND PH, FISCHER RL, SCHNORR KM et al.: Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus. Nature (2005) 437:975-980.
  • HARDER J, BARTELS J, CHRISTOPHERS E, SCHRODER JM: Isolation and characterization of human β-defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. (2001) 276:5707-5713.
  • CONEJO-GARCIA JR, JAUMANN F, SCHULZ S et al.: Identification of a novel, multifunctional β-defensin (hBD-3) with specific antimicrobial activity: its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell Tissue Res. (2001) 306:257-264.
  • LAY FT, ANDERSON MA: Defensins-components of the innate immune system in plants. Curr. Protein Pept. Sci. (2005) 6:85-101.
  • KLUVER E, ADERMANN K, SCHULZ A: Synthesis and structure–activity relationship of β-defensins, multi-functional peptides of the immune system. J. Pept. Sci. (2006) 12:243-257.
  • SCHIBLI DJ, HUNTER HN, ASEYEV V et al.: The solution structures of the human β-defensins lead to a better understanding of the potent bactericidal activity of HBD3 against Staphylococcus aureus. J. Biol. Chem. (2002) 277:8279-8289.
  • BAUER F, SCHWEIMER K, KLUVER E et al.: Structure determination of human and murine β-defensins reveals structural conservation in the absence of significant sequence similarity. Protein Sci. (2001) 10:2470-2479.
  • TANG YQ, YUAN J, OSAPAY G et al.: A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated α-defensins. Science (1999) 286:498-502.
  • TRABI M, SCHIRRA HJ, CRAIK DJ: Three-dimensional structure of RTD-1, a cyclic antimicrobial defensin from Rhesus macaque leukocytes. Biochemistry (2001) 40:4211-4221.
  • IMLER JL, BULET P: Antimicrobial peptides in Drosophila: structures, activities and gene regulation. Chem. Immunol. Allergy (2005) 86:1-21.
  • SELSTED ME, OUELLETTE AJ: Mammalian defensins in the antimicrobial immune response. Nat. Immunol. (2005) 6:551-557.
  • GANZ T: Defensins and other antimicrobial peptides: a historical perspective and an update. Comb. Chem. High Throughput Screen. (2005) 8:209-217.
  • CROVELLA S, ANTCHEVA N, ZELEZETSKY I et al.: Primate β-defensins-structure, function and evolution. Curr. Protein Pept. Sci. (2005) 6:7-21.
  • TORRES AM, KUCHEL PW: The β-defensin-fold family of polypeptides. Toxicon (2004) 44:581-588.
  • SUGIARTO H, YU PL: Avian antimicrobial peptides: the defense role of β-defensins. Biochem. Biophys. Res. Commun. (2004) 323:721-727.
  • LEHRER RI: Primate defensins. Nat. Rev. Microbiol. (2004) 2:727-738.
  • BROGDEN KA, ACKERMANN M, MCCRAY PB Jr, TACK BF: Antimicrobial peptides in animals and their role in host defences. Int. J. Antimicrob. Agents (2003) 22:465-478.
  • BULET P, STOCKLIN R: Insect antimicrobial peptides: structures, properties and gene regulation. Protein Pept. Lett. (2005) 12:3-11.
  • GANZ T, SELSTED ME, SZKLAREK D et al.: Defensins. Natural peptide antibiotics of human neutrophils. J. Clin. Invest. (1985) 76:1427-14235.
  • SELSTED ME, HARWIG SS, GANZ T, SCHILLING JW, LEHRER RI: Primary structures of three human neutrophil defensins. J. Clin. Invest. (1985) 76:1436-1439.
  • DANGL JL, JONES JD: Plant pathogens and integrated defence responses to infection. Nature (2001) 411:826-833.
  • MATSUZAKI K: Why and how are peptide-lipid interactionsutilized for self-defense? Magainins and tachyplesins as archetypes. Biochim. Biophys. Acta (1999) 1462:1-10.
  • SHAI Y: Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by α-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim. Biophys. Acta. (1999) 1462:55-70.
  • YANG L, WEISS T, LEHRER RI, HUANG HW: Crystallization of antimicrobial pores in membranes: magainin and protegrin. Biophys. J. (2000) 79:2002-2009.
  • PELEGRINI PB, FRANCO OL: Plant γ-thionins: novel insights on the mechanism of action of a multi-functional class of defense proteins. Int. J. Biochem. Cell Biol. (2005) 37:2239-2253.
  • BENSCH KW, RAIDA M, MAGERT HJ, SCHULZ-KNAPPE P, FORSSMANN WG: hBD-1: a novel β-defensin from human plasma. FEBS Lett. (1995) 368:331-335.
  • HARDER J, BARTELS J, CHRISTOPHERS E, SCHRODER JM: A peptide antibiotic from human skin. Nature (1997) 387:861.
  • COLE AM, HONG T, BOO LM et al.: Retrocyclin: a primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1. Proc. Natl. Acad. Sci. USA (2002) 99:1813-1818.
  • YANG D, CHERTOV O, BYKOVSKAIA SN et al.: β-Defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science (1999) 286:525-528.
  • CONEJO-GARCIA JR, KRAUSE A, SCHULZ S et al.: Human β-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. FASEB J. (2001) 15:1819-1821.
  • ZHOU CX, ZHANG YL, XIAO L et al.: An epididymis-specific β-defensin is important for the initiation of sperm maturation. Nat. Cell Biol. (2004) 6:458-464.
  • HIEMSTRA PS: Defensins and cathelicidins in inflammatory lung disease: beyond antimicrobial activity. Biochem. Soc. Trans. (2006) 34:276-278.
  • BARAK O, TREAT JR, JAMES WD: Antimicrobial peptides: effectors of innate immunity in the skin. Adv. Dermatol. (2005) 21:357-374.
  • BEVINS CL: Events at the host–microbial interface of the gastrointestinal tract. V. Paneth cell α-defensins in intestinal host defense. Am. J. Physiol. Gastrointest. Liver Physiol. (2005) 289:G173-G176.
  • WEHKAMP J, FELLERMANN K, STANGE EF: Human defensins in Crohn’s disease. Chem. Immunol. Allergy (2005) 86:42-54.
  • HARDER J, SCHRODER JM: Antimicrobial peptides in human skin. Chem. Immunol. Allergy (2005) 86:22-41.
  • BIRAGYN A: Defensins-non-antibiotic use for vaccine development. Curr. Protein Pept. Sci. (2005) 6:53-60.
  • LEHRER RI, GANZ T: Defensins of vertebrate animals. Curr. Opin. Immunol. (2002) 14:96-102.
  • DALE BA, KRISANAPRAKORNKIT S: Defensin antimicrobial peptides in the oral cavity. J. Oral Pathol. Med. (2001) 30:321-327.
  • PAZGIERA M, HOOVER DM, YANG D, LU W, LUBKOWSKI J: Human β-defensins. Cell Mol. Life Sci. (2006) 63:1294-1313.
  • YANG D, BIRAGYN A, HOOVER DM, LUBKOWSKI J, OPPENHEIM JJ: Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. Annu. Rev. Immunol. (2004) 22:181-215.
  • KLUVER E, SCHULZ-MARONDE S, SCHEID S, MEYER B, FORSSMANN WG, ADERMANN K: Structure-activity relation of human β-defensin 3: influence of disulfide bonds and cysteine substitution on antimicrobial activity and cytotoxicity. Biochemistry (2005) 44:9804-9816.
  • ZHANG L, YU W, HE T et al.: Contribution of human α-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor. Science (2002) 298:995-1000.
  • ZHANG L, LOPEZ P, HE T, YU W, HO DD: Retraction of an interpretation. Science (2004) 303:467.
  • MACKEWICZ CE, YUAN J, TRAN P et al.: α-Defensins can have anti-HIV activity but are not CD8 cell anti-HIV factors. AIDS (2003) 17:F23-F32.
  • CHANG TL, VARGAS J Jr, DELPORTILLO A, KLOTMAN ME: Dual role of α-defensin-1 in anti-HIV-1 innate immunity. J. Clin. Invest. (2005) 115:765-773.
  • WU Z, COCCHI F, GENTLES D et al.: Human neutrophil α-defensin 4 inhibits HIV-1 infection in vitro. FEBS Lett. (2005) 579:162-166.
  • SINHA S, CHESHENKO N, LEHRER RI, HEROLD BC: NP-1, a rabbit α-defensin, prevents the entry and intercellular spread of herpes simplex virus type 2. Antimicrob. Agents Chemother. (2003) 47:494-500.
  • BUCK CB, DAY PM, THOMPSON CD et al.: Human α-defensins block papillomavirus infection. Proc. Natl. Acad. Sci. USA (2006) 103:1516-1521.
  • SELSTED ME, TANG YQ, MORRIS WL et al.: Purification, primary structures, and antibacterial activities of β-defensins, a new family of antimicrobial peptides from bovine neutrophils. J. Biol. Chem. (1993) 268:6641-6648.
  • SCHUTTE BC, MITROS JP, BARTLETT JA et al.: Discovery of five conserved β-defensin gene clusters using a computational search strategy. Proc. Natl. Acad. Sci. USA (2002) 99:2129-2133.
  • RODRIGUEZ-JIMENEZ FJ, KRAUSE A, SCHULZ S et al.: Distribution of new human β-defensin genes clustered on chromosome 20 in functionally different segments of epididymis. Genomics (2003) 81:175-183.
  • QUINONES-MATEU ME, LEDERMAN MM, FENG Z et al.: Human epithelial β-defensins 2 and 3 inhibit HIV-1 replication. AIDS (2003) 17:F39-F48.
  • SUN L, FINNEGAN CM, KISH-CATALONE T et al.: Human β-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection. J. Virol. (2005) 79:14318-14329.
  • BIRAGYN A, RUFFINI PA, LEIFER CA et al.: Toll-like receptor 4-dependent activation of dendritic cells by β-defensin 2. Science (2002) 298:1025-1029.
  • KRISANAPRAKORNKIT S, KIMBALL JR, WEINBERG A, DARVEAU RP, BAINBRIDGE BW, DALE BA: Inducible expression of human β-defensin 2 by Fusobacterium nucleatum in oral epithelial cells: multiple signaling pathways and role of commensal bacteria in innate immunity and the epithelial barrier. Infect. Immun. (2000) 68:2907-2915.
  • FROHLICH O, PO C, YOUNG LG: Organization of the human gene encoding the epididymis-specific EP2 protein variants and its relationship to defensin genes. Biol. Reprod. (2001) 64:1072-1079.
  • IBRAHIM NM, YOUNG LG, FROHLICH O: Epididymal specificity and androgen regulation of rat EP2. Biol. Reprod. (2001) 65:575-580.
  • YENUGU S, HAMIL KG, FRENCH FS, HALL SH: Antimicrobial actions of human and macaque sperm associated antigen (SPAG) 11 isoforms: influence of the N-terminal peptide. Mol. Cell. Biochem. (2006) 13:1-13.
  • DUNSCHE A, ACIL Y, SIEBERT R, HARDER J, SCHRODER JM, JEPSEN S: Expression profile of human defensins and antimicrobial proteins in oral tissues. J. Oral. Pathol. Med. (2001) 30:154-158.
  • LU Q, SAMARANAYAKE LP, DARVEUA RP, JIN L: Expression of human β-defensin-3 in gingival epithelia. J. Periodontal Res. (2005) 40:474-481.
  • WANG W, COLE AM, HONG T, WARING AJ, LEHRER RI: Retrocyclin, an antiretroviral τ-defensin, is a lectin. J. Immunol. (2003) 170:4708-4716.
  • MUNK C, WEI G, YANG OO et al.: The τ-defensin, retrocyclin, inhibits HIV-1 entry. AIDS Res. Hum. Retroviruses (2003) 19:875-881.
  • WANG W, OWEN SM, RUDOLPH DL et al.: Activity of α- and τ-defensins against primary isolates of HIV-1. J. Immunol. (2004) 173:515-520.
  • OWEN SM, RUDOLPH DL, WANG W et al.: RC-101, a retrocyclin-1 analogue with enhanced activity against primary HIV type 1 isolates. AIDS Res. Hum. Retroviruses (2004) 20:1157-1165.
  • YASIN B, WANG W, PANG M et al.: τ-Defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry. J. Virol. (2004) 78:5147-5156.
  • LEIKINA E, DELANOE-AYARI H, MELIKOV K et al.: Carbohydrate-binding molecules inhibit viral fusion and entry by crosslinking membrane glycoproteins. Nat. Immunol. (2005) 6:995-1001.
  • MOTZKUS D, SCHULZ-MARONDE S, HEITLAND A et al.: The novel β-defensin DEFB123 prevents lipopolysaccharide- mediated effects in vitro and in vivo. FASEB J. (2006), (In Press).
  • THEVISSEN K, FRANCOIS IE, AERTS AM, CAMMUE BP: Fungal sphingolipids as targets for the development of selective antifungal therapeutics. Curr. Drug. Targets (2005) 6:923-928.
  • LIU YJ, CHENG CS, LAI SM, HSU MP, CHEN CS, LYU PC: Solution structure of the plant defensin VrD1 from mung bean and its possible role in insecticidal activity against bruchids. Proteins (2006) 63:777-786.
  • MELO FR, RIGDEN DJ, FRANCO OL et al.: Inhibition of trypsin by cowpea thionin: characterization, molecular modeling, and docking. Proteins (2002) 48:311-319.
  • LAY FT, BRUGLIERA F, ANDERSON MA: Isolation and properties of floral defensins from ornamental tobacco and petunia. Plant Physiol. (2003) 131:1283-1293.
  • FROY O: Convergent evolution of invertebrate defensins and nematode antibacterial factors. Trends Microbiol. (2005) 13:314-319.
  • CHAN YL, PRASAD V, SANJAYA et al.: Transgenic tomato plants expressing an Arabidopsis thionin (Thi2.1) driven by fruit-inactive promoter battle against phytopathogenic attack. Planta (2005) 221:386-393.
  • IWAI T, KAKU H, HONKURA R et al.: Enhanced resistance to seed-transmitted bacterial diseases in transgenic rice plants overproducing an oat cell-wall-bound thionin. Mol. Plant Microbe Interact. (2002) 15:515-521.
  • SALZMAN NH, GHOSH D, HUTTNER KM, PATERSON Y, BEVINS CL: Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature (2003) 422:522-526.
  • MOSER C, WEINER DJ, LYSENKO E, BALS R, WEISER JN, WILSON JM: β-Defensin 1 contributes to pulmonary innate immunity in mice. Infect. Immun. (2002) 70:3068-3072.
  • ELAHI S, BUCHANAN RM, ATTAH-POKU S, TOWNSEND HG, BABIUK LA, GERDTS V: The host defense peptide β-defensin 1 confers protection against Bordetella pertussis in newborn piglets. Infect. Immun. (2006) 74:2338-2352.
  • WELLING MM, HIEMSTRA PS, VAN DEN BARSELAAR MT et al.: Antibacterial activity of human neutrophil defensins in experimental infections in mice is accompanied by increased leukocyte accumulation. J. Clin. Invest. (1998) 102:1583-1590.
  • LANDON C, THOUZEAU C, LABBE H, BULET P, VOVELLE F: Solution structure of spheniscin, a β-defensin from the penguin stomach. J. Biol. Chem. (2004) 279:30433-30349.
  • YENUGU S, HAMIL KG, RADHAKRISHNAN Y, FRENCH FS, HALL SH: The androgen-regulated epididymal sperm-binding protein, human β-defensin 118 (DEFB118) (formerly ESC42), is an antimicrobial β-defensin. Endocrinology (2004) 145:3165-3173.
  • YENUGU S, HAMIL KG, BIRSE CE, RUBEN SM, FRENCH FS, HALL SH: Antibacterial properties of the sperm-binding proteins and peptides of human epididymis 2 (HE2) family; salt sensitivity, structural dependence and their interaction with outer and cytoplasmic membranes of Escherichia coli. Biochem. J. (2003) 372:473-483.

Patents

Website

  • http://www.pubmed.gov PubMed is a service of the US National Library of Medicine that includes over 16 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.